£120.94

Springer Current Advances in Osteosarcoma: Clinical Perspectives: Past, Present and Future: 1257 (Advances in Experimental Medicine and Biology, 1257)

Price data last checked 8 day(s) ago - will refresh soon

View at Amazon

Price History & Forecast

Last 83 days • 83 data points (No recent data available)

Historical
Generating forecast...
£120.94 £116.25 £117.28 £118.30 £119.32 £120.34 £121.37 24 January 2026 13 February 2026 06 March 2026 26 March 2026 16 April 2026

Price Distribution

Price distribution over 83 days • 2 price levels

Days at Price
Current Price
65 days 18 days · current 0 16 33 49 65 £117 £121 Days at Price

Price Analysis

Most common price: £117 (65 days, 78.3%)

Price range: £117 - £121

Price levels: 2 different prices over 83 days

Description

Product Description This thoroughly revised second edition complied in 2 books is an up-to-date overview of the current clinical advances in sarcoma and osteosarcoma. The new edition features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, these essential volumes also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists focused in sarcoma. From the Back Cover This thoroughly revised second edition complied in 2 books is an up-to-date overview of the current clinical advances in sarcoma and osteosarcoma. The new edition features detailed, in-depth discussions of microRNAs in osteosarcoma, historical perspectives of chemotherapy in the treatment of the disease, tumor targeted IL12 therapy and HER2 targeted therapy, the role of enhancer elements in regulating the prometastatic transcriptional program and more. Further, these essential volumes also includes new insights on Wnt signaling in osteosarcoma, the role of genomics, genetically modified T-cell therapy, liquid biopsy, oncolytic viruses, immunophenotyping, receptor tyrosine kinases and epigenetic-focused approaches for treatment of osteosarcoma metastases, as well as thoughts on the current standard of treatment for patients suffering from these cancers. In the years since the previous edition, there have been numerous new developments in this rapidly changing field; this new edition is both timely and urgently needed. When taken together these companion volumes, Current Clinical (Book 1) and Scientific (Book 2) Advances in Osteosarcoma, are a timely and urgently needed guide for laboratory investigators and clinical oncologists focused in sarcoma. About the Author Eugenie S. Kleinerman, holds the Mary V. and John A. Reilly Distinguished Chair, and is currently Professor at the University of Texas MD Anderson Cancer Center in the Departments of Pediatrics Research and Cancer Biology. Dr. Kleinerman is internationally recognized for her scientific and clinical expertise in sarcomas, particular osteosarcoma, and for pioneering the use of a unique immunotherapy agent, liposome-encapsulated MTP-PE, for patients with newly diagnosed osteosarcoma or unresponsive relapsed osteosarcoma lung metastases. Her current research interests include developing novel ways to treat sarcoma patients by identifying new therapeutic targets, the properties that influence metastases, the efficacy of dendritic cell vaccines with and without checkpoint inhibitors for osteosarcoma lung metastases, how tumor vessels are formed in Ewing sarcoma and the use of exercise interventions to mitigate chemotherapy-induced cardiotoxicity. Richard Gorlick, is currently the Mosbacher Pediatrics Chair of the Department of Pediatrics Patient Care, and Division Head of Pediatrics at the University of Texas MD Anderson Cancer Center. Dr. Gorlick is an internationally recognized expert in pediatric oncology and hematology, whose research and clinical work have focused on sarcomas, tumors that grow in connective tissues including bones, muscles, tendons and ca

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Management of Soft Tissue Sarcoma
98% match

Management of Soft Tissue Sarcoma

Springer

£87.90 15 Apr 2026
Animal Models in Cancer Drug Discovery
98% match

Animal Models in Cancer Drug Discovery

Academic Press

£117.49 05 Apr 2026
Pediatric and Adolescent Osteosarcoma: 152 (Cancer Treatment and Research, 152)
98% match

Pediatric and Adolescent Osteosarcoma: 152 (Cancer Treatment and Research, 152)

Springer

£180.00 15 Apr 2026
Imaging of Bone and Soft Tissue Tumors and Their Mimickers, An Issue of Radiologic Clinics of North America (Volume 60-2) (The Clinics: Internal Medicine, Volume 60-2)
98% match

Imaging of Bone and Soft Tissue Tumors and Their Mimickers, An Issue of Radiologic Clinics of North America (Volume 60-2) (The Clinics: Internal Medicine, Volume 60-2)

Elsevier

£83.49 14 Apr 2026
Surgery for Recurrent Soft Tissue Sarcoma: Barrier Resection and Reconstruction
98% match

Surgery for Recurrent Soft Tissue Sarcoma: Barrier Resection and Reconstruction

Springer

£106.57 19 Apr 2026
Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)
98% match

Diagnosis and Management of Malignant Solid Tumors in Infants and Children: 37 (Developments in Oncology, 37)

Springer

£103.65 10 Apr 2026
Horizons in Cancer Research: Volume 72
98% match

Horizons in Cancer Research: Volume 72

£109.98 20 Apr 2026
Malignant Pediatric Bone Tumors - Treatment & Management (Pediatric Oncology)
98% match

Malignant Pediatric Bone Tumors - Treatment & Management (Pediatric Oncology)

Springer

£76.86 10 Apr 2026
Pocket Oncology (Pocket Notebook Series)
98% match

Pocket Oncology (Pocket Notebook Series)

WOLTERS KLUWER HEALTH

£50.66 05 Apr 2026
Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)
97% match

Mathematical Oncology 2013 (Modeling and Simulation in Science, Engineering and Technology)

Birkhauser

£73.85 03 Apr 2026
The Bethesda Handbook of Clinical Oncology
97% match

The Bethesda Handbook of Clinical Oncology

WOLTERS KLUWER HEALTH

£55.55 12 Mar 2026
Conversing with Cancer: How to Ask Questions, Find and Share Information, and Make the Best Decisions: 22 (Language as Social Action)
97% match

Conversing with Cancer: How to Ask Questions, Find and Share Information, and Make the Best Decisions: 22 (Language as Social Action)

Peter Lang Gmbh, Internationaler Verlag Der Wissenschaften

£65.95 03 Apr 2026
Radiation Oncology and Radiotherapy Part B (Volume 174) (Methods in Cell Biology, Volume 174)
97% match

Radiation Oncology and Radiotherapy Part B (Volume 174) (Methods in Cell Biology, Volume 174)

Academic Press

£129.45 09 Apr 2026
Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)
97% match

Ovarian Cancers: Advances through International Research Cooperation (GINECO, ENGOT, GCIG)

Springer

£109.99 10 Apr 2026
Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)
97% match

Current Immunotherapeutic Strategies in Cancer: 214 (Recent Results in Cancer Research, 214)

Springer

£87.93 12 Apr 2026
Principles and Management of Cancer
97% match

Principles and Management of Cancer

Jaypee Brothers Medical Publishers

£145.81 03 Apr 2026
IMAGERIE RHUMATOLOGIQUE ET ORTHOPEDIQUE TOME 4 - TUMEURS OSSEUSES ET PSEUDO-TUME: Tome 4, Tumeurs osseuses ; Pseudo-tumeurs osseuses
97% match

IMAGERIE RHUMATOLOGIQUE ET ORTHOPEDIQUE TOME 4 - TUMEURS OSSEUSES ET PSEUDO-TUME: Tome 4, Tumeurs osseuses ; Pseudo-tumeurs osseuses

SAURAMPS MEDICA

£117.44 15 Apr 2026
From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)
97% match

From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)

Springer

£150.59 03 Apr 2026
Bone Metastases: A translational and clinical approach: 12 (Cancer Metastasis - Biology and Treatment, 12)
97% match

Bone Metastases: A translational and clinical approach: 12 (Cancer Metastasis - Biology and Treatment, 12)

Springer

£129.99 15 Apr 2026
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
97% match

Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease

Elsevier

£20.00 03 Apr 2026
Cutaneous Reactions from Anti-Cancer Therapies
97% match

Cutaneous Reactions from Anti-Cancer Therapies

WOLTERS KLUWER HEALTH

£58.22 14 Apr 2026
Etiology of Acute Leukemias in Children
97% match

Etiology of Acute Leukemias in Children

Springer

£116.55 10 Apr 2026
Cell Sources for iPSCs, Volume 7 (Advances in Stem Cell Biology, Volume 7)
97% match

Cell Sources for iPSCs, Volume 7 (Advances in Stem Cell Biology, Volume 7)

Academic Press

£116.98 05 Apr 2026
Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)
97% match

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Springer

£114.20 13 Apr 2026